Subclinical hypothyroidism and antithyroid autoantibodies in women with subfertility or recurrent pregnancy loss: Scientific Impact Paper No. 70 June 2022: Scientific Impact Paper No. 70 June 2022
Discussions around testing and subsequent management particularly relate to women with a history of subfertility or repeated miscarriages. This Scientific Impact Paper provides information on thyroid testing and the management of mild thyroid problems and thyroid antibodies in women with a history of subfertility or recurrent miscarriages, using the latest evidence and guidelines. It concludes that there may be a role for treating these women with thyroxine tablets (the hormone produced by the thyroid gland) when subclinical hypothyroidism is present, and gives guidance on the cut-off levels for treatment.PMID:35765760 | DOI:10.1111/1471-0528.17187
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Rima K Dhillon-Smith Kristien Boelaert Yadava B Jeve Abha Maheshwari Arri Coomarasamy Royal College of Obstetricians and Gynaecologists Source Type: research
More News: Babies | Hormones | Hypothyroidism | Miscarriage | OBGYN | Perinatology & Neonatology | Pregnancy | Premature Birth | Royal College of Obstetricians and Gynaecologists | Thyroid | Women